China Pioneer Pharma Holdings Limited
HKSE 1345.HK
China Pioneer Pharma Holdings Limited EBIT for the year ending December 31, 2023: USD 25.77 M
-
China Pioneer Pharma Holdings Limited EBIT for the year ending December 31, 2022 was USD 33.58 M, a 14.10% change year over year.
-
China Pioneer Pharma Holdings Limited EBIT for the year ending December 31, 2021 was USD 29.43 M, a 99.22% change year over year.
-
China Pioneer Pharma Holdings Limited EBIT for the year ending December 31, 2020 was USD 14.77 M, a -32.52% change year over year.
-
China Pioneer Pharma Holdings Limited EBIT for the year ending December 31, 2019 was USD 21.89 M, a 0.61% change year over year.
| Date | EBIT | EBITDA | Net Income | EPS (Diluted) |
|---|
| CEO | Mr. Yuewen Yang |
| IPO Date | Nov. 5, 2013 |
| Location | China |
| Headquarters | No.15, Lane 88 Wuwei Road |
| Employees | 319 |
| Sector | Health Care |
| Industries | |
China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. It also sells ancillary tools and leases accessories; and sells dental devices. In addition, the company engages in the sale of imported in-licensed prescription products. China Pioneer Pharma Holdings Limited was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. China Pioneer Pharma Holdings Limited is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.
Past 5 years
USD 0.12
USD 0.43
USD 0.29
StockViz Staff
January 15, 2025
Any question? Send us an email